2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Opiate-related Disorders: new trials by email Literature Review of Opiate-related Disorders trials Research Report on Opiate-related Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) buprenorphine, buprenorphine/naloxone - Opiate-related Disorders, Opiate Dependence | Phase 4 | Completed | Indivior Inc. | 60 | 2007-07-01 | 2023-03-20 |
| Starting Treatment With Agonist Replacement Therapies (START) Buprenorphine/naloxone, Methadone - Opiate-related Disorders | Phase 4 | Completed | University of California, Los Angeles | 1269 | 2006-04-01 | 2017-01-06 |
Opioid-Related Disorders (1) · Substance-Related Disorders (1)
Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1)
Buprenorphine, Naloxone Drug Combination (2) · Buprenorphine (1) · Methadone (1)
Indivior Inc. (1) · University of California, Los Angeles (1)
United States (1)
Andrew Saxon, M.D. (1) · Walter Ling, M.D. (1)
PMID 22921476, PMID 23961726, PMID 24751432, PMID 29333880, PMID 34328394, PMID 36063082, PMID 36655851, PMID 38616571
U10DA013045 (1)